Compare LPTH & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LPTH | BME |
|---|---|---|
| Founded | 1985 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Trusts Except Educational Religious and Charitable |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 563.1M | 547.5M |
| IPO Year | 2011 | 2005 |
| Metric | LPTH | BME |
|---|---|---|
| Price | $14.86 | $39.74 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $13.33 | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 49.0K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $37,202,630.00 | N/A |
| Revenue This Year | $83.04 | N/A |
| Revenue Next Year | $24.83 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 17.26 | N/A |
| 52 Week Low | $2.25 | $35.03 |
| 52 Week High | $15.24 | $42.74 |
| Indicator | LPTH | BME |
|---|---|---|
| Relative Strength Index (RSI) | 68.03 | 51.22 |
| Support Level | $9.60 | $37.71 |
| Resistance Level | $15.24 | $42.34 |
| Average True Range (ATR) | 1.15 | 0.89 |
| MACD | 0.45 | 0.25 |
| Stochastic Oscillator | 96.03 | 76.39 |
LightPath Technologies Inc manufactures, distributes, and integrates proprietary optical components and assemblies. It develops optical solutions for traditional optics and communications markets. The company's products include precision molded optics and infrared products, serving markets such as distribution, laser, industrial, instrumentation, telecommunications, and defense. Its products are categorized as infrared components, visible components, assemblies and modules, and engineering services. G5 Infrared's revenue mainly comes from infrared components and assemblies.
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.